218 related articles for article (PubMed ID: 29059467)
1. Telomere length and reactive oxygen species levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
Ko E; Seo HW; Jung G
Hepatology; 2018 Apr; 67(4):1378-1391. PubMed ID: 29059467
[TBL] [Abstract][Full Text] [Related]
2. Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma.
Ma LJ; Wang XY; Duan M; Liu LZ; Shi JY; Dong LQ; Yang LX; Wang ZC; Ding ZB; Ke AW; Cao Y; Zhang XM; Zhou J; Fan J; Gao Q
J Pathol; 2017 Dec; 243(4):407-417. PubMed ID: 28833123
[TBL] [Abstract][Full Text] [Related]
3. Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells.
Ko E; Jung G
Biochem Biophys Res Commun; 2014 May; 447(2):358-63. PubMed ID: 24732358
[TBL] [Abstract][Full Text] [Related]
4. Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Ningarhari M; Caruso S; Hirsch TZ; Bayard Q; Franconi A; Védie AL; Noblet B; Blanc JF; Amaddeo G; Ganne N; Ziol M; Paradis V; Guettier C; Calderaro J; Morcrette G; Kim Y; MacLeod AR; Nault JC; Rebouissou S; Zucman-Rossi J
J Hepatol; 2021 May; 74(5):1155-1166. PubMed ID: 33338512
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.
Sun B; Yu L; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
Cancer Sci; 2021 Jul; 112(7):2753-2769. PubMed ID: 33932069
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
7. Co-Upregulation of 14-3-3ζ and P-Akt is Associated with Oncogenesis and Recurrence of Hepatocellular Carcinoma.
Tang Y; Wang R; Zhang Y; Lin S; Qiao N; Sun Z; Cheng S; Zhou W
Cell Physiol Biochem; 2018; 45(3):1097-1107. PubMed ID: 29439255
[TBL] [Abstract][Full Text] [Related]
8. Decrease of MLK4 prevents hepatocellular carcinoma (HCC) through reducing metastasis and inducing apoptosis regulated by ROS/MAPKs signaling.
Li Y; Zuo H; Wang H; Hu A
Biomed Pharmacother; 2019 Aug; 116():108749. PubMed ID: 31071576
[TBL] [Abstract][Full Text] [Related]
9. PKCα promotes generation of reactive oxygen species via DUOX2 in hepatocellular carcinoma.
Wang J; Shao M; Liu M; Peng P; Li L; Wu W; Wang L; Duan F; Zhang M; Song S; Jia D; Ruan Y; Gu J
Biochem Biophys Res Commun; 2015 Aug; 463(4):839-45. PubMed ID: 26056003
[TBL] [Abstract][Full Text] [Related]
10. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling.
Zhou SL; Zhou ZJ; Hu ZQ; Li X; Huang XW; Wang Z; Fan J; Dai Z; Zhou J
Cancer Lett; 2015 Mar; 358(2):124-135. PubMed ID: 25462858
[TBL] [Abstract][Full Text] [Related]
11. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Romo1 promotes production of reactive oxygen species and invasiveness of hepatic tumor cells.
Chung JS; Park S; Park SH; Park ER; Cha PH; Kim BY; Chung YM; Woo SR; Han CJ; Kim SB; Suh KS; Jang JJ; Lee K; Choi DW; Lee S; Lee GY; Hahm KB; Shin JA; Kim BS; Noh KH; Kim TW; Lee KH; Yoo YD
Gastroenterology; 2012 Oct; 143(4):1084-94.e7. PubMed ID: 22749933
[TBL] [Abstract][Full Text] [Related]
13. Notch1 increases Snail expression under high reactive oxygen species conditions in hepatocellular carcinoma cells.
Kim HS; Jung G
Free Radic Res; 2014 Jul; 48(7):806-13. PubMed ID: 24684482
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
15. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells.
Ko E; Kim JS; Ju S; Seo HW; Chang Y; Kang JA; Park SG; Jung G
Hepatology; 2018 Nov; 68(5):1851-1864. PubMed ID: 29672884
[TBL] [Abstract][Full Text] [Related]
16. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
17. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis.
Plentz RR; Park YN; Lechel A; Kim H; Nellessen F; Langkopf BH; Wilkens L; Destro A; Fiamengo B; Manns MP; Roncalli M; Rudolph KL
Hepatology; 2007 Apr; 45(4):968-76. PubMed ID: 17393506
[TBL] [Abstract][Full Text] [Related]
18. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
19. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
[TBL] [Abstract][Full Text] [Related]
20. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
Wang C; Yao B; Xu M; Zheng X
Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
